Prof Alexandra Rowe develops ‘Depovax’ an anti-Malaria vaccine

Press/Media: Research

Period11 Oct 2016

Media coverage

5

Media coverage

  • TitlePositive preclinical data for Immunovaccine's DepoVax(TM)-based malarial vaccine presented at 2016 World Vaccine Congress Europe
    Degree of recognitionInternational
    Media name/outletMarket Wired
    Date11/10/16
    PersonsAlex Rowe
  • TitlePositive preclinical data for Immunovaccine's DepoVax(TM)-based malarial vaccine presented at 2016 World Vaccine Congress Europe
    Degree of recognitionInternational
    Media name/outletDow Jones Institutional News
    Date11/10/16
    PersonsAlex Rowe
  • TitlePositive preclinical data for Immunovaccine's DepoVax(TM)-based malarial vaccine presented at 2016 World Vaccine Congress Europe
    Degree of recognitionInternational
    Media name/outletCanada Stockwatch
    Date11/10/16
    PersonsAlex Rowe
  • TitlePositive preclinical data for Immunovaccine's DepoVax(TM)-based malarial vaccine presented at 2016 World Vaccine Congress Europe
    Degree of recognitionInternational
    Media name/outletNoticias Financieras
    Date11/10/16
    PersonsAlex Rowe
  • TitlePositive preclinical data for Immunovaccine's DepoVax(TM)-based malarial vaccine presented at 2016 World Vaccine Congress Europe
    Degree of recognitionInternational
    Media name/outletIndia Pharma News
    Date11/10/16
    PersonsAlex Rowe